AXT AXT surged 285% year to date topping options sentiment rankings. The $4.4B chip maker grabbed extreme trader conviction. ON ON Semiconductor claimed fifth place with 34% yearly gains and 79 RSI showing overbought territory.
AEHR Aehr Test Systems posted 263% gains yet faced wholesale insider exodus. Five executives dumped $19.6M last week showing coordinated selling. AVGO Broadcom insiders filed $17.8M in sales yesterday as chip leadership systematically liquidated positions.
CBIO Crescent Biopharma SI jumped 8.1 points in seven days. The $536M drugmaker hit 21.3% short interest up from 13.2% showing fastest mid-cap short surge. GLUE Monte Rosa Therapeutics climbed 7.8 points to 26.5% despite 19% yearly gains.
TYRA Tyra Biosciences topped high SI charts at 42.4%. Bears added 6 points weekly on the $1.9B oncology play. SPRY ARS Pharmaceuticals held 64.4% SI gaining 5.5 points as most-shorted stock over $800M market cap.
Oil markets faced extreme dislocation as Iran war entered week four. FT reported scramble for biodiesel triggered by crude squeeze. Prices dropped below regular diesel for first time as buyers rushed to secure replacements.
Wall Street banks started trading derivatives betting on private credit pain per FT reporting. JPMorgan and Barclays offered CDS on Apollo Ares and Blackstone funds. NXST Nexstar merger blocked by federal judge until antitrust lawsuit settles showing regulatory tightening.
Defense stocks captured analyst faith. NOC Northrop Grumman consensus target hit $736 as Wall Street raised forecasts. LMT Lockheed Martin target reached $668 reflecting sustained missile demand.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
